The opening year of the twenty-first century constitutes a watershed moment in the historical evolution of genomics, marking a shift from an exclusive, resource-intensive enterprise to a globally distributed, high-resolution discipline. This review summarises the main technological and conceptual developments that have been realised since the year 2000 up until 2025 and evaluates their implications on basic research, clinical translation and cross-national cooperation. Eponymous triumphs involve the achievement of the Human Genome Project and consequent definition of genome regulatory rootlessness, emergence of sequencing that is next generation, and occurrence of the high accuracy of world rudiments instruments such as the CRISPR Cas methods. In the same time, the advent of single-cell and spatial multi-omics has generated unmatched comprehension of cellular heterogeneity and tissue organization, while artificial intelligence has markedly expedited protein structure modeling, variant interpretation, and drug discovery. Several consortia, including those focused on large-scale coverage (e.g., GenomeAsia 100K and the Earth BioGenome Project), are broadening the coverage of reference genomes and their accessibility, and new ethical, legal, and policy issues are emerging to do so. Collectively, these developments have reconfigured discovery pathways, fostered precision medicine, and elevated the societal relevance of genomics. In the future, multimodal dataset integration using analytics powered by AI is expected to bring measurable gains to health, drive environmental stewardship and directional biological exploration.
Roy et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: